Establishment of additional pricing criteria over improved generic products eyed

The Ministry of Health and Welfare said on November 21 that the establishment of a new pricing standard for 130 generic drugs, which were excluded from this year's pricing re-evaluation programs, is to be promoted.

The framework for the pricing criteria will be prepared by the Korea Food and Drug Administration in terms of isomers, change in salts and sustained release formulation, according...